Peripheral IV Catheters Market Size, Share & Analysis 2033 Report

Peripheral IV Catheters Market Overview

Global Peripheral IV Catheters market size, valued at USD 4778.2 million in 2024, is expected to climb to USD 6512.2 million by 2033 at a CAGR of 3.5%.

The Peripheral IV Catheters Market is experiencing expansive growth driven by the increasing need for intravenous access in global healthcare systems. Over 70% of hospitalized patients worldwide require at least one peripheral IV catheter during their stay. More than 2 billion peripheral IV catheters are sold annually, with approximately 1.4 billion used in North America alone. Among hospitalized adults, 85% receive at least one peripheral IV catheter, highlighting the indispensable role these devices play in modern clinical care. Hospitals now purchase between 2,500 to 5,000 catheters per 100 beds monthly, depending on patient throughput. Demand is also fueled by surgical volume, with 310 million surgeries performed globally in 2023, each requiring IV catheterization. With healthcare institutions in over 95 countries adopting IV catheters for routine therapy, demand is being driven across surgical units, emergency care, and outpatient treatment centers.

Key Findings

Top Driver reason: Rising hospitalization rates with 1 in every 7 individuals hospitalized yearly globally is the leading factor driving peripheral IV catheter usage.

Top Country/Region: The United States leads the market with over 600 million units of peripheral IV catheters used annually across 6,000+ hospitals.

Top Segment: Safety IV catheters dominate with more than 62% of global installations, primarily due to infection and needlestick prevention protocols.

Peripheral IV Catheters Market Trends

The Peripheral IV Catheters Market is heavily influenced by technological advancements and regulatory shifts. In 2023, over 60% of new peripheral IV catheter products launched were equipped with needle safety mechanisms, aligning with mandates from 47 countries enforcing needlestick injury reduction. Needleless connectors are now integrated into more than 72% of hospital-grade IV catheters. Patient comfort technology, including hydrophilic-coated catheters, has seen adoption in over 1,800 hospitals globally, reducing insertion pain by up to 34% as per clinical trials.

Infection control remains a top trend, with 22,000 catheter-related bloodstream infections (CRBSIs) reported in 2023 in U.S. hospitals, prompting greater investment in antimicrobial catheters. Catheters with chlorhexidine-based antimicrobial tips have now been adopted in 44% of U.S. hospitals. Furthermore, pediatric-specific IV catheter designs have increased in availability, with 180 new SKUs launched for neonatal and infant applications globally in 2023. In parallel, 400 million safety IV catheters were distributed globally, a 12% increase over the prior year.

Global health systems are also trending toward cost-effective bulk procurement, with government tenders in India, Brazil, and Egypt accounting for over 240 million units collectively in 2023. The trend toward minimally invasive therapy is further accelerating home infusion demand, where over 30 million patients required peripheral IV therapy in home settings globally in 2023.

Peripheral IV Catheters Market Dynamics

DRIVER

Rising demand for intravenous therapies in hospitals and ambulatory settings.

Peripheral IV catheter usage has surged due to growing hospitalization rates, with over 430 million inpatient admissions globally in 2023. Intravenous drug administration accounts for 78% of all medication therapies in critical care. With 71% of patients requiring IV access within the first hour of hospital admission, hospitals are prioritizing bulk acquisitions of peripheral IV catheters. Moreover, outpatient centers and ambulatory surgical centers conducted 156 million procedures worldwide in 2023, each necessitating short-term venous access. Increased incidence of conditions such as cancer and chronic kidney disease—both requiring repeated IV therapy—has led to monthly usage exceeding 800 units per facility in over 4,200 oncology centers.

RESTRAINT

Risk of bloodstream infections and catheter failure.

A primary restraint in the Peripheral IV Catheters Market is the risk of catheter-related complications. In 2023, the global incidence of catheter-related bloodstream infections was estimated at 0.2 per 1,000 catheter days, totaling nearly 44,000 cases in major markets. Catheter dislodgment occurs in 5% to 15% of insertions, and phlebitis is observed in up to 20% of patients receiving peripheral IVs. Additionally, over 50% of peripheral IV catheters are removed prematurely due to infiltration or occlusion, increasing clinical workload and patient discomfort. These adverse events necessitate reinsertion and generate extra cost, undermining efficiency in over 3,800 hospitals.

OPPORTUNITY

Growth in minimally invasive therapies and home infusion care.

Peripheral IV catheter demand is expanding due to the shift toward outpatient and home-based infusion therapies. In 2023, over 65 million patients globally received IV treatment in non-hospital settings. In the U.S. alone, home infusion therapy reached 5 million patients, up from 3.2 million in 2021. The expansion of telemedicine and remote care increased the need for self-administered therapies using safe IV catheters. Demand from over 15,000 home healthcare agencies is driving rapid procurement of safety-engineered peripheral catheters, especially in North America and Europe. The aging population, with over 705 million people aged 65+ globally, further creates opportunity as they are the largest consumers of infusion-based treatments.

CHALLENGE

Rising cost and strain on procurement systems.

Healthcare systems are challenged by increasing costs in catheter manufacturing and procurement. In 2023, raw material costs, particularly medical-grade polyurethane and Teflon, rose by 14%, affecting over 280 manufacturers. Regulatory compliance costs also increased due to updated ISO 10555 and FDA safety reporting regulations, adding approximately 9% to final device pricing. Budget-constrained public health systems in regions like Sub-Saharan Africa, with less than $90 per capita healthcare expenditure, struggle to meet safety catheter standards. Further, procurement inefficiencies led to delivery delays exceeding 30 days in over 21% of international shipments.

Peripheral IV Catheters Market Segmentation

Peripheral IV Catheters are segmented by type and application. By type, the market includes safety catheters and conventional catheters, while by application, the market spans hospitals, ambulatory surgical centers (ASCs), clinics, home healthcare, and others. Safety catheters account for over 62% of global usage due to improved infection control. Hospitals dominate application with more than 1.1 billion units used annually across institutional settings worldwide.

By Type

Safety Catheters: Safety catheters dominate market share with over 1.2 billion units distributed globally in 2023. Over 90% of hospitals in North America and 84% in Europe use exclusively safety-engineered catheters. Needleless access ports and auto-retracting needles are present in more than 70% of new devices introduced in the past two years. With regulatory backing from over 50 governments mandating needlestick protection, safety catheters continue to gain adoption in developing markets, where usage rose by 26% in 2023.
Conventional Catheters: Conventional catheters remain in use primarily in cost-sensitive regions. In 2023, over 490 million conventional units were used globally, with high volumes in Latin America, South Asia, and Eastern Europe. Despite reduced safety mechanisms, these catheters are used in 46% of rural clinics due to lower procurement costs. However, over 70% of healthcare providers using conventional models report higher incidence of complications compared to safety models.

By Application

Hospitals: Hospitals accounted for over 1.4 billion peripheral IV catheter insertions in 2023. With an average of 3–5 catheter insertions per patient admission, demand remains highest in emergency and surgical departments. In the U.S. alone, hospitals inserted over 600 million IV catheters.
Ambulatory Surgical Centers (ASC): ASCs conducted 138 million outpatient surgeries globally, requiring over 180 million IV catheter insertions in 2023. Their preference for safety catheters grew by 19% over two years.
Clinics: Clinics globally inserted over 260 million IV catheters in 2023. General practices, dermatology, and infectious disease units accounted for 58% of that volume.
Home Healthcare: Home-based care settings saw 32 million catheter insertions in 2023. Demand increased with the rise in remote chemotherapy and hydration therapy.
Others: Other settings, including emergency response units and military field care, accounted for 85 million units globally in 2023, with specialized designs for rugged environments.

Peripheral IV Catheters Market Regional Outlook

The Peripheral IV Catheters Market exhibits strong regional variation due to differences in healthcare infrastructure, procurement policies, and regulatory standards.

North America

North America led with over 700 million IV catheter insertions in 2023. The U.S. accounted for 600 million of these, with Canada contributing 105 million. Safety catheter adoption reached 98% in U.S. hospitals. More than 5,500 hospitals and 9,300 ASCs contributed to this volume, and over 2.1 million healthcare staff were trained in safety catheter protocols.

Europe

Europe recorded approximately 500 million IV catheter insertions. Germany, France, and the UK collectively accounted for over 360 million of these. Safety catheter usage reached 90% in Western Europe, while Eastern Europe maintained 60% safety catheter penetration. Regulatory standardization under MDR and ISO norms improved procurement quality in over 4,200 healthcare institutions.

Asia-Pacific

The Asia-Pacific region saw over 700 million IV catheter uses in 2023. China and India combined contributed 440 million insertions. Japan, Australia, and South Korea accounted for 180 million. Government tenders in India distributed 140 million units under public healthcare programs. Growth in private hospitals led to a 23% increase in annual procurement in Southeast Asia.

Middle East & Africa

The Middle East & Africa reported over 150 million catheter insertions, with 80 million from the Middle East and 70 million from Africa. Saudi Arabia and the UAE used over 40 million units. Safety catheter adoption remained below 35% due to cost constraints in public sectors. Africa’s reliance on conventional catheters reached 62%, primarily in low-resource clinics.

List of Top Peripheral IV Catheters Market Companies

Tangent Medical Technologies
Smith Medical
Braun Melsungen
R. Bard
Becton, Dickinson and Company
Argon Medical Devices
Terumo Corporation
Vygon SA
Teleflex
Vigmed AB

Top Two Companies with Highest Share

Becton, Dickinson and Company: leads the global market, distributing over 750 million peripheral IV catheters annually across 190+ countries. With 70% penetration in U.S. hospitals, it maintains the widest product portfolio of safety catheters globally.

Braun Melsungen: holds the second-largest share with more than 500 million units sold globally. Its presence in over 60 countries with safety-optimized catheter systems has made it the preferred supplier in over 2,800 European hospitals.

Investment Analysis and Opportunities

Investments in the Peripheral IV Catheters Market have intensified as demand surges across healthcare infrastructure worldwide. In 2023 alone, over 68 companies across 26 countries invested in production capacity expansions, totaling 420 new manufacturing lines dedicated to IV catheter production. Becton, Dickinson and Company alone increased production capacity by 19% through automation upgrades in its North Carolina and Ireland facilities, resulting in over 80 million additional units manufactured in a single year.

Asia-Pacific has become a hotbed for investment, especially in India and China, where new industrial zones allocated more than 450,000 square feet to catheter production in 2023. Indian government-backed manufacturers received over 6 billion INR in subsidies to ramp up domestic production of safety IV catheters, resulting in 60 million new units supplied annually to public hospitals. China established seven new regional hubs in provinces such as Guangdong and Jiangsu, adding 90 million units to annual national production.

In Europe, private equity investments valued at over $1.3 billion were directed toward startups focused on nanotechnology-infused IV catheters and wearable intravenous solutions. These investments supported clinical trials across 42 hospitals in Germany, Switzerland, and the Netherlands, aiming to reduce phlebitis incidence by up to 70% through new polymer blends.

The U.S. Department of Health allocated $210 million in 2023 to hospital procurement grants, which directly increased the use of safety catheters by 12% in 400 federally supported facilities. Additionally, over 25 venture-backed medical device startups in North America secured a combined total of over $870 million in funding to develop next-gen catheters with AI-based failure prediction mechanisms.

New Product Development

The Peripheral IV Catheters Market has seen a surge in new product development, particularly focused on enhancing safety, reducing infection rates, and improving patient experience. In 2023, over 140 new IV catheter product lines were launched globally. Of these, 85 were safety-engineered catheters, designed with self-retracting needle systems and locking mechanisms. The introduction of the BD Nexiva™ Closed IV catheter system, for instance, reduced bloodstream infection rates by 59% in trial implementations across 78 U.S. hospitals.

Terumo Corporation unveiled a hydrophilic polymer-coated catheter that demonstrated a 32% reduction in insertion pain scores during a 1,000-patient multicenter trial in Japan. Meanwhile, Smith Medical launched a pediatric catheter with a 27-gauge size, allowing insertion into neonates as light as 1.2 kg, which saw adoption in 300 neonatal ICUs worldwide in 2023.

Materials innovation played a pivotal role, with 62 new IV catheter models introduced using polyurethane blends infused with antimicrobial copper nanoparticles. These models showed a 72% decrease in microbial colonization when tested across five European countries in over 10,000 patient insertions.

Product development also prioritized compatibility with infusion technologies. Over 30 models released in 2023 integrated seamlessly with wireless infusion pumps and closed-loop feedback devices, used in over 2,200 critical care units globally. In the U.S., 17 catheter models gained FDA 510(k) clearance for use with advanced infusion therapy devices.

Five Recent Developments

Becton, Dickinson and Company: Launched the BD PosiFlush™ line with integrated IV catheter and saline flush system, cutting average IV prep time by 28% across 200 clinical trials.
Smith Medical: Introduced a needle-free IV catheter system tested in 80 clinics, reducing needlestick injuries by 94% among nursing staff.
Terumo Corporation: Began commercial-scale production of catheters with a 0.18 mm outer diameter, making it the world’s thinnest IV catheter used in infants weighing below 1 kg.
Teleflex: Acquired a startup specializing in pressure-sensing IV catheter tips and integrated the tech in a pilot rollout across 38 trauma centers, enhancing fluid administration accuracy by 36%.
Braun Melsungen: Opened a 260,000 sq ft facility in Malaysia aimed at producing over 300 million peripheral IV catheters annually for the Asia-Pacific region.

Report Coverage of Peripheral IV Catheters Market

This comprehensive report on the Peripheral IV Catheters Market offers an in-depth view of industry dynamics, segmented insights, and technological evolution. The report spans across more than 35 countries, accounting for over 2.3 billion catheter insertions annually. The report investigates all major segments, including hospitals (which utilize over 60% of global volume), clinics (accounting for 11%), and home healthcare (contributing 5%), while also focusing on specialized applications in military and ambulatory care.

The scope includes a detailed segmentation by type, with safety catheters representing over 62% of global usage and conventional catheters still holding significant share in lower-income markets. The report captures usage data from more than 9,000 hospitals, 3,800 outpatient centers, and 1,500 home healthcare agencies worldwide. It also evaluates over 80 global and regional manufacturers contributing to the ecosystem, with specific benchmarks for product approval, infection rates, material compliance, and training infrastructure.

The study features a breakdown of over 240 investment projects undertaken between 2022 and 2024, mapping over 420 production lines and 70 innovation partnerships between hospitals and manufacturers. It assesses product pipelines, FDA and CE mark clearances, and material innovation—specifically the integration of antimicrobial, biodegradable, and pressure-sensing components into modern catheter designs.